Dear editor,
We present the case of a patient, who developed a severe systematic paranoid delusion secondary to treatment with clomiphene.
Clomiphene is a selective estrogen receptor modulator which belongs to the same class of drugs as tamoxiphene. It is used as an ovulation inducer for treating infertility. From a psychiatric point of view we are interested in the psychopathological side effects. In normal healthy women clompihene and other SERMs induce mood lability in up to 50% of the cases. However more severe alterations of mood and cognition are quite rare. A PubMed search revealed six cases of psychosis and severe cognitive abnormalities in the context of clomiphene treatment (Cashman and Sheppard, 1982; Oyffe et al., 1997) . A summary of these cases is provided in Table 1 .
Case report
Ms. B. was a 35-year-old woman who came to our psychiatric hospital after a week during which she developed a paranoid delusion. She had a history of depression which was treated 10 years ago with a SSRI and psychotherapy. Since then her mood has been stable. Ms. B. was working as an executive in a large German software company. She received a doctorate in mathematics and was working in the software quality management. She started taking 25 mg clomiphene after failure of getting pregnant in the past. One day after her first dose of clomiphene, she noticed a change in her working environment which was described by her as a "vanishing of background noise", which means that she had the impression colleagues talked only to her, no other conversations between colleagues took place. Form the third day on she started to experience ideas of reference, her chief was making hidden suggestions and she had the idea that something was going on. At the end of the week she was quite disturbed and after working for 14 hours she suddenly had the idea that the whole working environment was nothing than a test of her capabilities. She called this the assessment-centre situation, which meant that her whole behaviour was evaluated by a hidden evaluation team. More and more she suffered from paranoid ideas, which meant, that her husband, a 42-year-old free-working theologian, was at the centre of a complex conspiracy. The plot of this conspiracy was to test the ability of the software company to react in a "worstcase scenario" in the appropriate way. Her fear was that the software company would cease to exist when she was not able to deliver this message On the day of admission, B. showed agitated and aggressive behavior and was brought by her husband in our hospital. A mental status examination showed psychomotoric agitation and slight ideas of reference.
We started treatment with 10 mg olanzapine. EEG, brain MR and laboratory testing revealed no abnormalities. A neurological examination was negative.
After two days her BPRS dropped from 42 to 28, delusions counting for most of the points. She was able to reflect upon her delusions in a very logical way. She rejected the suggestion that e.g. a foreign secret agency was behind the conspiracy as "unusual" and "Hollywood-like". Since she had the impression, that the whole scenario converged on a critical day, she began feeling quite hopeless one day before that. To her surprise nothing bad happened on this day and the rest of her delusion vanished within three days. At first, she left the belief of the "worst-case scenario" instead she favoured the explanation of an assessment-centre situation. At the end of her treatment she was convinced that the whole episode was an accident due to the clomiphene treatment. She was released and continued an ambulant psychiatric treatment with olanzapine for six months. She continued working in her former company.
Discussion
Via pubmed-search ("clomiphene", "delusion" and "psychosis" as search terms) we discovered eight cases of psychotic syndromes due to clomiphene, none of them presenting as a circumscribed delusional disorder. Siedentopf et al. describe the case of a 32-year-old woman with severe formal thought disorder three days after the beginning of clomiphene treatment (Siedentopf et al., 1997) . Kapfhammer et al. describe the case of a 25 year old with a former history of manic-depressive disease and disturbance of consciousness, psychomotoric abnormalities and a paranoid-hallucinatory syndrome with transient neurological dysfunction (Kapfhammer et al., 1990) . In both cases there was a clear psychiatric history highlighting a vulnerability trait.
There are two possible mechanisms for the development of delusion due to clomiphene treatment. The first points to the interaction with the dopime system: Spitzer provided a model for delusions on the basis of a neural network where he simulated different dopamine levels via the gain-parameter (Spitzer, 1995) . Rats treated with the selective estrogen receptor modulator tamoxifene show a much higher dopamine signal in the nigrostriatal system (McDermott et al., 2001 ) . This may be the underlying cause of the delusional formation in our patient, 
